Palatin Technologies, Inc. (PTN)
Largest Insider Buys in Sector
PTN Stock Price History Chart
PTN Stock Performance
About Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a …
Insider Activity of Palatin Technologies, Inc.
Over the last 12 months, insiders at Palatin Technologies, Inc. have bought $12,703 and sold $44,766 worth of Palatin Technologies, Inc. stock.
On average, over the past 5 years, insiders at Palatin Technologies, Inc. have bought $70,309 and sold $23,447 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DEVEER ROBERT K JR (director) — $12,703.
The last purchase of 6,000 shares for transaction amount of $12,703 was made by DEVEER ROBERT K JR (director) on 2024‑04‑11.
List of Insider Buy and Sell Transactions, Palatin Technologies, Inc.
| 2024-08-01 | Sale | Executive VP and CFO/COO | 4,999 0.0253% | $1.66 | $8,274 | -19.53% | ||
| 2024-04-11 | director | 6,000 0.0394% | $2.12 | $12,703 | -14.25% | |||
| 2024-03-06 | Sale | director | 11,700 0.0789% | $2.00 | $23,434 | -8.06% | ||
| 2023-12-06 | Sale | Executive VP and CFO/COO | 4,998 0.0341% | $2.51 | $12,563 | -27.91% | ||
| 2023-12-04 | Sale | director | 200 0.0014% | $2.48 | $496 | -22.93% | ||
| 2022-12-27 | President and CEO | 10,000 0.093% | $2.23 | $22,297 | +4.28% | |||
| 2022-12-27 | Executive VP and CFO/COO | 10,000 0.0928% | $2.22 | $22,245 | +4.28% | |||
| 2022-12-21 | Sale | director | 200 0.002% | $2.97 | $594 | -16.67% | ||
| 2021-07-01 | director | 10,000 0.0041% | $0.61 | $6,100 | -30.65% | |||
| 2021-07-01 | director | 33,000 0.0139% | $0.62 | $20,460 | -30.65% | |||
| 2021-06-30 | President and CEO | 75,000 0.0319% | $0.62 | $46,394 | -29.51% | |||
| 2021-06-30 | Executive VP and CFO/COO | 75,000 0.0318% | $0.62 | $46,238 | -29.51% | |||
| 2021-06-30 | director | 20,000 0.0085% | $0.62 | $12,350 | -29.51% | |||
| 2020-11-18 | director | 54,000 0.0215% | $0.41 | $22,140 | +25.00% | |||
| 2020-09-29 | Sale | director | 54,000 0.0219% | $0.46 | $24,980 | +14.58% | ||
| 2019-08-05 | director | 800 0.0003% | $0.78 | $627 | -16.67% | |||
| 2019-08-02 | President and CEO | 20,000 0.0088% | $0.86 | $17,260 | -20.24% | |||
| 2019-08-01 | President and CEO | 30,000 0.0128% | $0.86 | $25,859 | -22.41% | |||
| 2019-08-01 | Executive VP and CFO/COO | 50,000 0.0214% | $0.86 | $43,250 | -22.41% | |||
| 2019-08-01 | director | 22,580 0.0096% | $0.86 | $19,419 | -22.41% |
Insider Historical Profitability
| WILLS STEPHEN T | Executive VP and CFO/COO | 235456 1.2045% | $1.07 | 10 | 2 | <0.0001% |
| DUNTON ALAN W | director | 45074 0.2306% | $1.07 | 10 | 3 | +11.66% |
| DEVEER ROBERT K JR | director | 40845 0.2089% | $1.07 | 5 | 2 | <0.0001% |
| Hull Joseph Stanley | director | 775966 3.9695% | $1.07 | 5 | 0 | <0.0001% |
| Morris Arlene | director | 698666 3.5741% | $1.07 | 2 | 0 | +0.62% |
Institutional Investor Ownership
| The Vanguard Group | $1.11M | 3.68 | 594,491 | +8.36% | +$85,775.09 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $273,761.00 | 0.91 | 146,396 | 0% | +$0 | <0.0001 | |
| BlackRock | $223,499.00 | 0.74 | 119,518 | 0% | +$0 | <0.0001 | |
| Geode Capital Management | $220,991.00 | 0.73 | 118,160 | +25.5% | +$44,908.90 | <0.0001 | |
| Squarepoint Ops LLC | $101,623.00 | 0.34 | 54,344 | New | +$101,623.00 | <0.0001 |